Differential response to preoperative exercise training in patients candidates to cardiac valve replacement.


Journal

BMC anesthesiology
ISSN: 1471-2253
Titre abrégé: BMC Anesthesiol
Pays: England
ID NLM: 100968535

Informations de publication

Date de publication:
09 Aug 2024
Historique:
received: 17 05 2024
accepted: 01 08 2024
medline: 10 8 2024
pubmed: 10 8 2024
entrez: 9 8 2024
Statut: epublish

Résumé

There is lack of evidence regarding safety, effectiveness and applicability of prehabilitation on cardiac surgery population, particularly in patients candidates to cardiac valve replacement. The aim of the study is to assess and compare the effect of a multimodal prehabilitation program on functional capacity in patients with severe aortic stenosis (AoS) and severe mitral regurgitation (MR) proposed for valve replacement surgery. Secondary analysis from a randomised controlled trial whose main objective was to analyze the efficacy of a 4-6 weeks multimodal prehabilitation program in cardiac surgery on reducing postoperative complications. For this secondary analysis, only candidates for valve replacement surgery were selected. The primary outcome was the change in endurance time (ET) from baseline to preoperative assessment measured by a cycling constant work-rate cardiopulmonary exercise test. 68 patients were included in this secondary analysis, 34 (20 AoS and 14 MR) were allocated to the prehabilitation group and 34 (20 AoS and 14 MR) to control group. At baseline, patients with AoS had better left systolic ventricular function and lower prevalence of atrial fibrillation compared to MR (p = 0.022 and p = 0.035 respectively). After prehabilitation program, patients with MR showed greater improvement in ET than AoS patients (101% vs. 66% increase from baseline). No adverse events related to the prehabilitation program were observed. A 4-6 week exercise training program is safe and overall improves functional capacity in patients with severe AoS and MR. However, exercise response is different according to the cardiac valve type disfunction, and further studies are needed to know the factors that predispose some patients to have better training response. The study has been registered on the Registry of National Institutes of Health ClinicalTrials.gov (NCT03466606) (05/03/2018).

Sections du résumé

BACKGROUND BACKGROUND
There is lack of evidence regarding safety, effectiveness and applicability of prehabilitation on cardiac surgery population, particularly in patients candidates to cardiac valve replacement. The aim of the study is to assess and compare the effect of a multimodal prehabilitation program on functional capacity in patients with severe aortic stenosis (AoS) and severe mitral regurgitation (MR) proposed for valve replacement surgery.
METHODS METHODS
Secondary analysis from a randomised controlled trial whose main objective was to analyze the efficacy of a 4-6 weeks multimodal prehabilitation program in cardiac surgery on reducing postoperative complications. For this secondary analysis, only candidates for valve replacement surgery were selected. The primary outcome was the change in endurance time (ET) from baseline to preoperative assessment measured by a cycling constant work-rate cardiopulmonary exercise test.
RESULTS RESULTS
68 patients were included in this secondary analysis, 34 (20 AoS and 14 MR) were allocated to the prehabilitation group and 34 (20 AoS and 14 MR) to control group. At baseline, patients with AoS had better left systolic ventricular function and lower prevalence of atrial fibrillation compared to MR (p = 0.022 and p = 0.035 respectively). After prehabilitation program, patients with MR showed greater improvement in ET than AoS patients (101% vs. 66% increase from baseline). No adverse events related to the prehabilitation program were observed.
CONCLUSIONS CONCLUSIONS
A 4-6 week exercise training program is safe and overall improves functional capacity in patients with severe AoS and MR. However, exercise response is different according to the cardiac valve type disfunction, and further studies are needed to know the factors that predispose some patients to have better training response.
TRIAL REGISTRATION BACKGROUND
The study has been registered on the Registry of National Institutes of Health ClinicalTrials.gov (NCT03466606) (05/03/2018).

Identifiants

pubmed: 39123146
doi: 10.1186/s12871-024-02671-x
pii: 10.1186/s12871-024-02671-x
doi:

Banques de données

ClinicalTrials.gov
['NCT03466606']

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

280

Subventions

Organisme : Instituto de Salud Carlos III
ID : PI17/00852
Organisme : Instituto de Salud Carlos III
ID : PI17/00852
Organisme : Instituto de Salud Carlos III
ID : PI17/00852
Organisme : Instituto de Salud Carlos III
ID : PI17/00852
Organisme : Instituto de Salud Carlos III
ID : PI17/00852
Organisme : Instituto de Salud Carlos III
ID : PI17/00852
Organisme : Instituto de Salud Carlos III
ID : PI17/00852
Organisme : Instituto de Salud Carlos III
ID : PI17/00852
Organisme : Instituto de Salud Carlos III
ID : PI17/00852

Informations de copyright

© 2024. The Author(s).

Références

McCann M, Stamp N, Ngui A, Litton E. Cardiac Prehabilitation. J Cardiothorac Vasc Anesth. 2019;33(8):2255–65.
doi: 10.1053/j.jvca.2019.01.023 pubmed: 30765210
Drudi LM, Tat J, Ades M, et al. Preoperative Exercise Rehabilitation in Cardiac and vascular interventions. J Surg Res. 2019;237(514):3–11.
doi: 10.1016/j.jss.2018.11.042 pubmed: 30694788
Sawatzky JAV, Kehler DS, Ready AE, et al. Prehabilitation program for elective coronary artery bypass graft surgery patients: a pilot randomized controlled study. Clin Rehabil. 2014;28(7):648–57.
doi: 10.1177/0269215513516475 pubmed: 24459173
Coca-Martinez M, Lopez-Hernandez A, Montane-Muntane M et al. Multimodal prehabilitation as strategy for reduction of postoperative complications after cardiac surgery: a randomised controlled trial protocol. BMJ Open. 2020;10(12).
Vahanian A, Beyersdorf F, Praz F, et al. ESC/EACTS guidelines for the management of valvular heart disease. Eur Heart J. 2022;43(7):561–632.
doi: 10.1093/eurheartj/ehab395 pubmed: 34453165
Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40(5):373–83.
doi: 10.1016/0021-9681(87)90171-8 pubmed: 3558716
Nashef SA, Roques F, Sharples LD, et al. EuroSCORE II. Eur J Cardiothorac Surg. 2012;41(4):734–44.
doi: 10.1093/ejcts/ezs043 pubmed: 22378855
Levett DZH, Jack S, Swart M, et al. Perioperative cardiopulmonary exercise testing (CPET): consensus clinical guidelines on indications, organization, conduct, and physiological interpretation. Br J Anaesth. 2018;120(3):484–500.
doi: 10.1016/j.bja.2017.10.020 pubmed: 29452805
ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. 2002;166(1):111–7.
doi: 10.1164/ajrccm.166.1.at1102
Jones CJ, Rikli RE, Beam WC. A 30-s chair-stand test as a measure of Lower Body Strength in community-residing older adults. Res Q Exerc Sport. 1999;70:2:113–9.
doi: 10.1080/02701367.1999.10608028 pubmed: 10380242
Struthers R, Erasmus P, Holmes K, Warman P, Collingwood A, Sneyd JR. Assessing fitness for surgery: a comparison of questionnaire, incremental shuttle walk, and cardiopulmonary exercise testing in general surgical patients. Br J Anaesth. 2008;101(6):774–80.
doi: 10.1093/bja/aen310 pubmed: 18953057
Donaire-Gonzalez D, Gimeno-Santos E, Serra I, et al. Validation of the Yale Physical Activity Survey in chronic obstructive pulmonary disease patients. Arch Bronconeumol. 2011;47(11):552–60.
doi: 10.1016/j.arbres.2011.07.002 pubmed: 21975081
Van der Molen MC, Slebos DJ, Augustijn SWS, Kerstjens HAM, Hartman JE. The minimal important difference of the constant work rate cycle test in severe COPD. Respir Med 2023; 215.
Puente-Maestu L, Palange P, Casaburi R, et al. Use of exercise testing in the evaluation of interventional efficacy: an official ERS statement. Eur Respir J. 2016;47(2):429–60.
doi: 10.1183/13993003.00745-2015 pubmed: 26797036
Puente-Maestu L, Villar F, de Miguel J, et al. Clinical relevance of constant power exercise duration changes in COPD. Eur Respir J. 2009;34(2):340–5.
doi: 10.1183/09031936.00078308 pubmed: 19251787
Minnella EM, Awasthi R, Gillis C, et al. Patients with poor baseline walking capacity are most likely to improve their functional status with multimodal prehabilitation. Surgery. 2016;160(4):1070–9.
doi: 10.1016/j.surg.2016.05.036 pubmed: 27476586
Ross R, de Lannoy L, Stotz PJ. Separate Effects of Intensity and Amount of Exercise on Interindividual Cardiorespiratory Fitness Response. Mayo Clin Proc. 2015; 90(11):1506-14.
Pandey A, Swift DL, McGuire DK, et al. Metabolic effects of Exercise Training among Fitness-nonresponsive patients with type 2 diabetes: the HART-D Study. Diabetes Care. 2015;38(8):1494–501.
doi: 10.2337/dc14-2378 pubmed: 26084342 pmcid: 4512133
Chatrath N, Papadakis M. Physical activity and exercise recommendations for patients with valvular heart disease. Heart. 2022;108(24):1938–44.
doi: 10.1136/heartjnl-2021-319824 pubmed: 35236765
Akowuah EF, Wagnild JM, Bardgett M et al. A randomised controlled trial of prehabilitation in patients undergoing elective cardiac surgery. Anaesthesia. 2023 Jul 4. Epub ahead of print.
Bonow RO, Nishimura RA, Thompson PD, Udelson JE. Eligibility and disqualification recommendations for competitive athletes with Cardiovascular abnormalities: Task Force 5: Valvular Heart Disease: A Scientific Statement from the American Heart Association and American College of Cardiology. Circulation. 2015;132(22):e292–7.
doi: 10.1161/CIR.0000000000000241 pubmed: 26621646
Eser P, Trachsel LD, Marcin T, Herzig D, Freiburghaus I, De Marchi S, et al. Short- and Long-Term effects of high-intensity interval training vs. moderate-intensity continuous training on left ventricular remodeling in patients early after ST-Segment Elevation myocardial infarction-the HIIT-EARLY randomized controlled trial. Front Cardiovasc Med. 2022;9:869501–869501.
doi: 10.3389/fcvm.2022.869501 pubmed: 35783836 pmcid: 9247394

Auteurs

Antonio López-Hernández (A)

Anesthesiology Department, Hospital Clínic de Barcelona, Barcelona, Spain.
Prehabilitation Unit, Hospital Clínic de Barcelona, Barcelona, Spain.

Elena Gimeno-Santos (E)

Prehabilitation Unit, Hospital Clínic de Barcelona, Barcelona, Spain.
August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
Barcelona of Global Health Institute (ISGlobal) - Universitat Pompeu Fabra (UPF), Barcelona, Spain.
CIBER de Enfermedades Respiratorias (CIBERES), Carlos III Health Institute, Madrid, Spain.

Ricard Navarro-Ripoll (R)

Anesthesiology Department, Hospital Clínic de Barcelona, Barcelona, Spain.
Prehabilitation Unit, Hospital Clínic de Barcelona, Barcelona, Spain.
August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.

María José Arguis (MJ)

Anesthesiology Department, Hospital Clínic de Barcelona, Barcelona, Spain.
Prehabilitation Unit, Hospital Clínic de Barcelona, Barcelona, Spain.
August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.

Bárbara Romano-Andrioni (B)

Prehabilitation Unit, Hospital Clínic de Barcelona, Barcelona, Spain.
Nutrition and Clinical Dietetics, Hospital Clínic de Barcelona, Barcelona, Spain.

Manuel López-Baamonde (M)

Anesthesiology Department, Hospital Clínic de Barcelona, Barcelona, Spain.
Prehabilitation Unit, Hospital Clínic de Barcelona, Barcelona, Spain.

Silvia Teres (S)

Prehabilitation Unit, Hospital Clínic de Barcelona, Barcelona, Spain.

María Sanz-de la Garza (M)

August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain.
Cardiovascular Institute, Hospital Clínic de Barcelona, Barcelona, Spain.

Graciela Martinez-Palli (G)

Anesthesiology Department, Hospital Clínic de Barcelona, Barcelona, Spain. GMARTIN@clinic.cat.
Prehabilitation Unit, Hospital Clínic de Barcelona, Barcelona, Spain. GMARTIN@clinic.cat.
August Pi i Sunyer Biomedical Research Institute (IDIBAPS), Barcelona, Spain. GMARTIN@clinic.cat.
CIBER de Enfermedades Respiratorias (CIBERES), Carlos III Health Institute, Madrid, Spain. GMARTIN@clinic.cat.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH